Pharmacogenomics: its role in re-establishing coumarin as treatment for lymphedema.

doi:10.1089/lrb.2005.3.81

Back to search

Article

Pharmacogenomics: its role in re-establishing coumarin as treatment for lymphedema.

Lymphatic research and biology - 1 Jan 2005

Farinola Nicholas, Piller Neil

Abstract excerpt

Although there remains some significant controversy regarding the use and benefits of coumarin (5,6-benzo-alpha pyrone), it would seem that targeted appropriate and monitored use of the drug does have a significant role in the treatment of lymphedemas. The particular benefits are its cost and ease of administration. Given today's demands for high level investigative clinical trials, it would be virtually...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Flavonoids

Share to Lymphedema

Share to Mixed Function Oxygenases

Share to Pharmacogenetics

Share to Polymorphism, Single Nucleotide

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Pharmacogenomics: its role in re-establishing coumarin as treatment for lymphedema.PMID 16000056Read

Coumarin-induced Hepatotoxicity: A Narrative ReviewSemantic proximity Read

[Pharmacogenomics in dermatology].Semantic proximity Read

Pharmacogenomics.Semantic proximity Read

Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions.Semantic proximity Read

Mechanistic insights into the biochemical and pharmacological profile of esculetinSemantic proximity Read

Integration of clinical and gene expression endpoints to explore furan-mediated hepatotoxicitySemantic proximity Read

A pharmacogenomics primer.Semantic proximity Read

Biostatistic tools in pharmacogenomics--advances, challenges, potential.Semantic proximity Read